EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study

Jill Maggs, Gregory S Sawicki, Callie Bacon, Emma McWilliams, Dana Yablon, Benjamin Ertman, Liam Sweeney, Jennifer L Butcher, Robin S Everhart, Michelle Prickett, Christopher Siracusa, Alex H Gifford und 5 weitere

Contemporary Clinical Trials · 2025

DOI: 10.1016/j.cct.2024.107752 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2025. Verfasst von Jill Maggs und 16 weiteren Autor:innen. Beteiligte Einrichtung: Community Member, former STRC Steering Committee Member, c/o Cystic Fibrosis Foundation, 4550 Montgomery Avenue, Suite 1100 N, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Drug Combinations, Qualitative Research. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: As people with cystic fibrosis (PWCF) live longer due to the breakthrough drug elexacaftor-tezacaftor-ivacaftor (ETI), they have questioned whether other CF therapies could be safely discontinued. SIMPLIFY was the first prospective, randomized trial to evaluate non-inferiority of discontinuing versus continuing two therapies. The QUEST (Qualitative Understanding of Experiences in the SIMPLIFY Trial) study was conducted to understand experiences of PWCF enrolled in SIMPLIFY, including why they joined, perceptions of randomization, decision-making around study withdrawal, and considerations for future discontinuation studies. METHODS: QUEST enrolled SIMPLIFY participants 14 years or older stable on ETI and caregivers of the 14-17 year-olds. Interviews were audio-recorded, transcribed, and coded. A phenomenological approach was used to inductively develop codes with no a priori hypotheses; identified themes were then organized around current research and recruitment literature. RESULTS: 114 interviews were completed (68 adults, 23 teenagers, and 23 caregivers). Among PWCF, median age was 27.8 years, 49 % were female and 80 % had participated in research before SIMPLIFY. Five themes were identified: (1) Experience with SIMPLIFY randomization, [2] Trust, [3] Altruism, [4] Perceived personal benefits, and [5]) Perceived risks and protocol burden. CONCLUSION: QUEST findings highlight how a long-standing culture of research and thoughtful protocol design contributed to SIMPLIFY's successful recruitment and retention. This included understanding the importance of remaining in the trial despite not being randomized to their preferred treatment assignment. Using patient-centered approaches to select research questions, design a protocol to minimize participant barriers, and frame recruitment materials messaging contribute to successful research participation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisDrug CombinationsQualitative ResearchHumansFemaleMaleAdolescentAdultYoung AdultQuinolonesCaregiversBenzodioxolesIndolesAminophenolsProspective StudiesDecision MakingEquivalence Trials as TopicPyrazolesPyridinesQuinolines

Stichwörter der Autor:innen

Cystic fibrosisDiscontinuation trialResearch participation

Substanzen

Drug Combinationselexacaftor, ivacaftor, tezacaftor drug combinationQuinolonesBenzodioxolesIndolesAminophenolsPyrazolesPyridinesQuinolines

Autor:innen und Institutionen

  • Community Member, former STRC Steering Committee Member, c/o Cystic Fibrosis Foundation, 4550 Montgomery Avenue, Suite 1100 N, Bethesda, MD, USA.
  • Division of Pulmonary Medicine, Boston Children's Hospital, 333 Longwood Avenue, Boston, MA, USA.
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, 5501 Hopkins Bayview Circle, Baltimore, MD, USA.
  • Department of Pediatrics, Division of Pediatric Psychology, Mott Children's Hospital, University of Michigan Health, Ann Arbor, MI, USA.
  • Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
  • Division of Pulmonary and Critical Care, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Förderung

  • Cystic Fibrosis Foundation
  • Cystic Fibrosis Foundation Therapeutics Inc

Zitieren

APA

Maggs, J., Sawicki, G. S., Bacon, C., McWilliams, E., Yablon, D., Ertman, B., Sweeney, L., Butcher, J. L., Everhart, R. S., Prickett, M., Siracusa, C., Gifford, A. H., Mayer-Hamblett, N., Nichols, D. P., Goodman, A., Woo, T., & Riekert, K. A. (2025). Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2024.107752

Vancouver

Maggs J, Sawicki GS, Bacon C, McWilliams E, Yablon D, Ertman B, et al. Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study. Contemporary Clinical Trials. 2025. doi:10.1016/j.cct.2024.107752

BibTeX
@article{Maggs2025,
  author = {Maggs, Jill and Sawicki, Gregory S and Bacon, Callie and McWilliams, Emma and Yablon, Dana and Ertman, Benjamin and Sweeney, Liam and Butcher, Jennifer L and Everhart, Robin S and Prickett, Michelle and Siracusa, Christopher and Gifford, Alex H and Mayer-Hamblett, Nicole and Nichols, David P and Goodman, Andrea and Woo, Tia and Riekert, Kristin A},
  title = {Qualitative understanding of experiences of people with cystic fibrosis in a treatment discontinuation trial: The QUEST study},
  journal = {Contemporary Clinical Trials},
  year = {2025},
  doi = {10.1016/j.cct.2024.107752}
}
Kostenlos starten →